Cargando…

Efficacy and Tolerability of Cranial Electrotherapy Stimulation in the Treatment of Anxiety: A Systemic Review and Meta-Analysis

OBJECTIVE: We aimed to investigate the efficacy and tolerability of cranial electrotherapy stimulation (CES) for patients with anxiety symptoms. METHOD: We searched the Pubmed, Cochrane Central Register of Controlled Trials (CENTRAL), Embase and Medline for randomized control trials (RCTs) from the...

Descripción completa

Detalles Bibliográficos
Autores principales: Ching, Pao-Yuan, Hsu, Tien-Wei, Chen, Guan-Wei, Pan, Chih-Chuan, Chu, Che-Sheng, Chou, Po-Han
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218324/
https://www.ncbi.nlm.nih.gov/pubmed/35757229
http://dx.doi.org/10.3389/fpsyt.2022.899040
_version_ 1784731861238415360
author Ching, Pao-Yuan
Hsu, Tien-Wei
Chen, Guan-Wei
Pan, Chih-Chuan
Chu, Che-Sheng
Chou, Po-Han
author_facet Ching, Pao-Yuan
Hsu, Tien-Wei
Chen, Guan-Wei
Pan, Chih-Chuan
Chu, Che-Sheng
Chou, Po-Han
author_sort Ching, Pao-Yuan
collection PubMed
description OBJECTIVE: We aimed to investigate the efficacy and tolerability of cranial electrotherapy stimulation (CES) for patients with anxiety symptoms. METHOD: We searched the Pubmed, Cochrane Central Register of Controlled Trials (CENTRAL), Embase and Medline for randomized control trials (RCTs) from the time of inception until November 15, 2021, following Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. Data were pooled using a random-effects model. The primary outcomes were the mean change scores for anxiety symptoms. The secondary outcomes were the mean change scores for depressive symptoms. RESULTS: Eleven RCTs were eligible (n = 794, mean age: 41.4, mean population of female: 64.8%). CES significantly reduced the anxiety symptoms compared to the control group [k = 11, n = 692, Hedge's g = −0.625, 95% confidence intervals (CIs) = −0.952 to −0.298, P < 0.001] with moderate effect size. The subgroup analysis showed that CES reduced both primary and secondary anxiety (primary anxiety, k =3, n = 288, Hedges' g = −1.218, 95% CIs = −1.418 to −0.968, P = 0.007; secondary anxiety, k = 8, n = 504, Hedges' g = −0.334, 95% CIs = −0.570 to −0.098, P = 0.006). After performing between group analysis, we found CES has significant better efficacy for patients with primary anxiety than those with secondary anxiety (P < 0.001). For secondary outcome, CES significantly reduced depressive symptoms in patients with anxiety disorders (k = 8, n = 552, Hedges' g = −0.648, 95% CIs = −1.062 to −0.234, P = 0.002). No severe side effects were reported and the most commonly reported adverse events were ear discomfort and ear pain. CONCLUSION: We found CES is effective in reducing anxiety symptoms with moderate effect size in patients with both primary and secondary anxiety. Furthermore, CES was well-tolerated and acceptable. Systematic Review Registration: PROSPERO, https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021267916.
format Online
Article
Text
id pubmed-9218324
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-92183242022-06-24 Efficacy and Tolerability of Cranial Electrotherapy Stimulation in the Treatment of Anxiety: A Systemic Review and Meta-Analysis Ching, Pao-Yuan Hsu, Tien-Wei Chen, Guan-Wei Pan, Chih-Chuan Chu, Che-Sheng Chou, Po-Han Front Psychiatry Psychiatry OBJECTIVE: We aimed to investigate the efficacy and tolerability of cranial electrotherapy stimulation (CES) for patients with anxiety symptoms. METHOD: We searched the Pubmed, Cochrane Central Register of Controlled Trials (CENTRAL), Embase and Medline for randomized control trials (RCTs) from the time of inception until November 15, 2021, following Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. Data were pooled using a random-effects model. The primary outcomes were the mean change scores for anxiety symptoms. The secondary outcomes were the mean change scores for depressive symptoms. RESULTS: Eleven RCTs were eligible (n = 794, mean age: 41.4, mean population of female: 64.8%). CES significantly reduced the anxiety symptoms compared to the control group [k = 11, n = 692, Hedge's g = −0.625, 95% confidence intervals (CIs) = −0.952 to −0.298, P < 0.001] with moderate effect size. The subgroup analysis showed that CES reduced both primary and secondary anxiety (primary anxiety, k =3, n = 288, Hedges' g = −1.218, 95% CIs = −1.418 to −0.968, P = 0.007; secondary anxiety, k = 8, n = 504, Hedges' g = −0.334, 95% CIs = −0.570 to −0.098, P = 0.006). After performing between group analysis, we found CES has significant better efficacy for patients with primary anxiety than those with secondary anxiety (P < 0.001). For secondary outcome, CES significantly reduced depressive symptoms in patients with anxiety disorders (k = 8, n = 552, Hedges' g = −0.648, 95% CIs = −1.062 to −0.234, P = 0.002). No severe side effects were reported and the most commonly reported adverse events were ear discomfort and ear pain. CONCLUSION: We found CES is effective in reducing anxiety symptoms with moderate effect size in patients with both primary and secondary anxiety. Furthermore, CES was well-tolerated and acceptable. Systematic Review Registration: PROSPERO, https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021267916. Frontiers Media S.A. 2022-06-09 /pmc/articles/PMC9218324/ /pubmed/35757229 http://dx.doi.org/10.3389/fpsyt.2022.899040 Text en Copyright © 2022 Ching, Hsu, Chen, Pan, Chu and Chou. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Ching, Pao-Yuan
Hsu, Tien-Wei
Chen, Guan-Wei
Pan, Chih-Chuan
Chu, Che-Sheng
Chou, Po-Han
Efficacy and Tolerability of Cranial Electrotherapy Stimulation in the Treatment of Anxiety: A Systemic Review and Meta-Analysis
title Efficacy and Tolerability of Cranial Electrotherapy Stimulation in the Treatment of Anxiety: A Systemic Review and Meta-Analysis
title_full Efficacy and Tolerability of Cranial Electrotherapy Stimulation in the Treatment of Anxiety: A Systemic Review and Meta-Analysis
title_fullStr Efficacy and Tolerability of Cranial Electrotherapy Stimulation in the Treatment of Anxiety: A Systemic Review and Meta-Analysis
title_full_unstemmed Efficacy and Tolerability of Cranial Electrotherapy Stimulation in the Treatment of Anxiety: A Systemic Review and Meta-Analysis
title_short Efficacy and Tolerability of Cranial Electrotherapy Stimulation in the Treatment of Anxiety: A Systemic Review and Meta-Analysis
title_sort efficacy and tolerability of cranial electrotherapy stimulation in the treatment of anxiety: a systemic review and meta-analysis
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218324/
https://www.ncbi.nlm.nih.gov/pubmed/35757229
http://dx.doi.org/10.3389/fpsyt.2022.899040
work_keys_str_mv AT chingpaoyuan efficacyandtolerabilityofcranialelectrotherapystimulationinthetreatmentofanxietyasystemicreviewandmetaanalysis
AT hsutienwei efficacyandtolerabilityofcranialelectrotherapystimulationinthetreatmentofanxietyasystemicreviewandmetaanalysis
AT chenguanwei efficacyandtolerabilityofcranialelectrotherapystimulationinthetreatmentofanxietyasystemicreviewandmetaanalysis
AT panchihchuan efficacyandtolerabilityofcranialelectrotherapystimulationinthetreatmentofanxietyasystemicreviewandmetaanalysis
AT chuchesheng efficacyandtolerabilityofcranialelectrotherapystimulationinthetreatmentofanxietyasystemicreviewandmetaanalysis
AT choupohan efficacyandtolerabilityofcranialelectrotherapystimulationinthetreatmentofanxietyasystemicreviewandmetaanalysis